Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.

What symbol and exchange does Enovis shares trade?

Enovis trades on the NYSE stock market under the symbol ENOV.

What is Enovis stock price doing today?

As of October 23, 2026, ENOV stock price declined to $21.08 with 879,562 million shares trading.

What is Enovis's Beta?

ENOV has a beta of 1.07, meaning it tends to be more sensitive to market movements. ENOV has a correlation of 0.05 to the broad based SPY ETF.

How much is Enovis worth?

ENOV has a market cap of $1.22 billion. This is considered a Small Cap stock.

How much money does Enovis make?

Last quarter Enovis reported $583 million in Revenue and $.90 earnings per share. This beat revenue expectation by $141,456 and exceeded earnings estimates by $.06.

What is the highest and lowest price Enovis traded in the last 3 year period?

In the last 3 years, ENOV traded as high as $65.03 and as low as $16.70.

What are the top ETFs holding Enovis?

The top ETF exchange traded funds that ENOV belongs to (by Net Assets): IJR, AVUV, VTI, IWM, VB.

Is Enovis (ENOV) a good investment?

ENOV has underperformed the market in the last year with a return of -35.2%, while the SPY ETF gained +14.3%. In the last 3 month period, ENOV fell short of the market, returning -19.1%, while SPY returned +3.2%. However, in the most recent 2 weeks ENOV has outperformed the stock market by returning +19.2%, while SPY returned -2.4%.

What are the support and resistance levels for Enovis (ENOV)?

ENOV support price is $20.95 and resistance is $22.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ENOV shares will trade within this expected range on the day.